Medical Cannabis Bill Passes in Kentucky Senate Committee
On March 14, Senate Bill 47 was reviewed in the Senate Licensing & Occupations Committee voted 8-3, which will now move forward to the Senate floor. One of the bill’s sponsors, Sen. Stephen West, spoke at the meeting. “I didn’t intend to ever get into medical marijuana or take a look at the issue,” West explained. He added that two advocates from Mason County, Eric and Michelle Crawford, inspired him to look closer into medical cannabis and its potential benefits. West reviewed the bill in its current version, which would allow medical cannabis for patients with “any type of cancer regardless of stage, chronic, severe, intractable, or debilitating pain, epilepsy or any other intractable seizure disorder, multiple sclerosis, muscle spasms or spasticity, chronic nausea or cyclical vomiting, post-traumatic stress disorder, and then we added one recently, any other medical condition or disease for which the Kentucky Center for Cannabis finds appropriate.” Although smoking cannabis would be prohibited, raw cannabis would be permitted for vaping purposes. Cultivating cannabis for personal use would not be permitted either. The program would be managed by The Cabinet for Health and Family Services, and regulations would be finalized by Jan. 1, 2025. “I know it’s been a long road to this committee and I want to commend you for your vigilance and on this bill,” committee chair John Schnickel said in reply. “I have been working with you and people who have carried this bill before you for years. And you are an example to us all of in class and the way to handle yourself on a controversial issue which people feel passionately about in both directions.” The committee also heard from longtime advocate Eric Crawford, who became a quadriplegic in the 1990s when he was involved in an automotive accident that broke his…
Excerpt only …
READ MORE BELOW
Source : Medical Cannabis Bill Passes in Kentucky Senate Committee
reposted by Cannabis News World
You must log in to post a comment.